Clinical Trial

PET Imaging of MMP Activation in AAA: Clinical Component

Study acronym: PET AAA
Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
A first-in-human evaluation of \[64Cu\]-RYM2 with PET/CT will be performed to: a) assess its safety, biodistribution, and radiation dosimetry in normal volunteers (WU) and; b) in AAA patients undergoing surgery (WU and Yale), evaluate radiotracer pharmacodynamics and correlate PET imaging characteristics (WU) with ex vivo tissue measurements (Yale).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-11.
Trial Details
NCT Number NCT07473102
Lead Sponsor Washington University School of Medicine
Conditions Abdominal Aortic Aneurysm
Enrollment 28 participants
Start Date 2025-11-03
Primary Completion 2027-03-31 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-18